BackAEON Biopharma Overview

AEON Biopharma Total Assets

Track AEON Biopharma's total assets ($8.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$8.63M
↓ 37.46% YoYΔ $-5.17M vs prior year quarter

Peer average

Loading

AEON Biopharma Total Assets History

Loading

AEON Biopharma vs. peers: Total Assets Comparison

Loading

AEON Biopharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AEON Biopharma (AEON) FAQ

The latest total assets for AEON is $8.6M as of March 2026. That compares with $14M in the prior-year period — down 37.5% year over year. Investors often review this figure alongside AEON Biopharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, AEON's total assets moved from $14M to $8.6M — a 37.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AEON Biopharma's operating scale or balance-sheet position.

A total assets figure of $8.6M for AEON is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AEON's total assets ($8.6M), review year-over-year change from $14M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.